From Discovery Park to Merck, Major Industry Players to Showcase at London Biotechnology Show 2025

London, November 4: Back for its second year, the London Biotechnology Show (#LBS25) gathers prominent biotech leaders, policymakers, and industry enthusiasts for an unparalleled showcase. Attendees can look forward to an impressive roster of returning sponsors and exhibitors with enhanced packages, alongside a diverse array of new participants.

Discovery Park has registered as the Gold Sponsor of #LBS25, setting a high standard for excellence in biotech innovation. Joining them, Haier Biomedical UK Ltd, Ellab, and Mathys & Squire have secured their places as Silver Sponsors, while Cool Repair System, Homogenising Systems Ltd, and Merck as Bronze Sponsors.

The exhibition also features an impressive lineup of influential biotech innovators, including Stratagem IPM, LI-Cor Bioscience Ltd, Restore Harrow Green, NIHR, FORMULATRIX, Clarity Compliance Solutions, Brookhouse, BRAND Scientific, Synbiosis, LAUDA Technology, Carterra, ProteoGenix, Life4sciences, Adelphi Healthcare Packaging, IKA, Appleton Woods, Firefinch Software, Integra Biosciences, Exeter Science Park, Miltenyi Biotec, Sterilem Bioscience, Eppendorf, Bishop Simon, LS Scientific, Guardtech Group, Orion GXP Consulting, Fieldfare Consulting, Oxartis, All Med Pro, and INDICRO, highlighting promising ventures with the potential to drive future biotech breakthroughs.

To provide fresh insights into today’s most pressing biotech challenges, the conference boasts a distinguished lineup of speakers including representatives from leading organizations, like Google, Novo Nordisk, Microsoft, Bayer Pharmaceuticals, the Medicines and Healthcare products Regulatory Agency, Genomics England, and AstraZeneca. Notable participants who further enrich the event with their expertise include:

• Dr. Bryn Roberts, Global Head of Data, Analytics & Research, Roche Information Solutions
• Professor Sir Mark Caulfield, Vice Principal for Health, Faculty of Medicine and Dentistry, Queen Mary University of London
• Professor Andrew M Wardley, Executive Chair, The Association of Cancer Physicians, Royal College of Physicians
• Dr. Nicole Mather, Health & Life Sciences Leader, IBM
• Professor Bola Owolabi, Vice President, Royal Society for Public Health
• Charles Lowe, CEO, Digital Health & Care Alliance
• Dr. Stephen Ward, Chief Manufacturing Officer, Cell and Gene Therapy Catapult
• Professor Jon Dawson, Director of the Centre for Human Development, Stem Cells and Regeneration, University of Southampton
• Dr. Shazia Iqbal, Member, The Royal Society of Medicine
• Khaudeja Bano, Vice President - Global Head of Device Quality, Genentech (Roche Group)

#LBS25 presents an array of dynamic sessions, including keynote speeches, interactive discussions, and panels. Participants have an incredible opportunity to explore cutting-edge topics in biotechnology, covering gene editing, pharmaceuticals, regenerative medicine, agriculture, bioinformatics, and much more. This conference doesn’t only offer a glimpse into the future of biotechnology but also present actionable insights for today’s biotech professionals.

Recognising the power of collaboration, #LBS25’s Hosted Buyer Programme offers attendees and participants a unique opportunity to connect with sponsors and exhibitors through pre-arranged, one-on-one meetings. This tailored matchmaking approach enables biotech professionals to expand their networks, discover complementary solutions, and establish valuable partnerships.

Don’t miss out on this extraordinary opportunity to witness the forefront of biotech innovation. Register now to secure your place at #LBS25 and connect with the industry's most influential leaders.

For more information, please contact: press@valiantandcompany.com

By Muhammad Younis, PR & Communications at Valiant Business Media